FDA Plans for Cannabinoids Claims and CBD

Live Webinar

  • 60 minutes

The webinar will cover the current regulatory status of Cannabidiol(CBD) ,FDA plans for CBD (Cannabidiol) Claims and future regulation and plans for revision of FDA’s “Healthy Claim”. It will also cover recent FDA actions regarding CBD product marketing that violates FDA regulations. This session will convey an understanding of FDA plans to revise the current “Healthy” claim and what to expect.  It will also convey likely FDA plans to address the challenging regulation of Cannabidiol (CBD) and what actions the Agency is taking regarding CBD claims that violate the law.

Join this session with our expert Norma Skolnic, Where You will be provided guidance on how to obtain research information and understand the current market for Cannabidiol (CBD) in the U.S.

Session Highlights :

  • Current status of Cannabidiol (CBD) regulation and likely plans for future regulation

  • FDA position on marketed CBD products and claims

  • FDA Actions RE: CBD Claims

  • Legal and illegal marketing of Cannabinoids

  • Cannabis as 'food'

  • Regulatory and future trends for cannabinoids in the United States

Why Should You Attend:

Cannabinoids are a hot topic in the current food industry. Knowledge of the current FDA approvals and research being reported will assist in predicting the future of this class of compounds and deciding whether a given firm wants to be part of it. You will be provided guidance on how to obtain research information and understand the current market for Cannabidiol (CBD) in the U.S.

Who Will Benefit:

  • Pharmaceutical executives

  • Research and development professionals in pharmaceutical companies

  • Regulatory affairs personnel in pharmaceutical companies

  • Food Executive

  • Quality Professionals

  • Regulatory Compliance Officer

  • Marketing and Business managers

  • Attorneys working with CBD products

*You may ask your Question directly to our expert during the Q&A session.

** You can buy On-Demand and view it as per your convenience.

Norma Skolnik

Norma Skolnik

Norma Skolnik is currently a Regulatory Consultant with over 35 years of regulatory experience working with the pharmaceutical and dietary supplement industries. She was Director of Regulatory Affairs for the Americas for Cadbury Adams and Director of Regulatory Affairs for the Adams division of Pfizer before that. Prior to that she was Associate Director of Regulatory Affairs for the Warner-Lambert company and Associate Director Regulatory Affairs at American Home Products Whitehall-Robbins Division.

No Reviews Found

Want to attend in a Group? Call 844-810-1151 and Save upto 50%

Share this course with a friend


Get Notified about News, Webinars, Community & More